Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Genetic Technologies Ltd (NASDAQ:GENE)

2.14
Delayed Data
As of Aug 27
 +0.08 / +3.88%
Today’s Change
1.04
Today|||52-Week Range
11.00
+11.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash5.5M9.1M1.6M2.7M
 
 
 
 
 
Short Term Investment Cash1.8M3.9M-7.3M1.0M
 
 
 
 
 
Cash & Short Term Investments5.5M9.1M1.8M2.7M
 
 
 
 
 
 
ReceivablesReceivables722.0K449.0K300.8K1.0M
 
 
 
 
 
 
InventoriesInventories302.6K324.6K195.7K201.0K
 
 
 
 
 
 
Current AssetsPrepaid Expenses204.5K224.9K168.8K190.6K
 
 
 
 
 
Other Current Assets214.1261.7K2.8K0.00
 
 
 
 
Current Assets6.7M10.2M2.4M4.1M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross7.0M6.4M5.7M5.5M
 
 
 
 
 
Depreciation-6.0M-5.7M-5.3M-5.1M
 
 
 
 
 
Intangible Assets1.8M1.5M1.2M1.1M
 
 
 
 
 
Other Assets1.8M1.5M1.2M1.1M
 
 
 
 
 
Total Assets9.6M16.9M7.6M6.4M
 
 
 
 
 
 
LiabilitiesAccounts Payable699.2K341.0K569.5K849.7K
 
 
 
 
 
Short Term Debt72.7K18.2K0.000.00
 
 
 
Accrued Expenses172.3K236.4K343.7K223.8K
 
 
 
 
 
Other Current Liabilities669.7K860.8K983.2K662.7K
 
 
 
 
 
Other Liabilities2.2M2.0M2.3M2.2M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.000.002.4M
 
 
Total Liabilities2.3M2.1M2.3M4.6M
 
 
 
 
 
 
EquityMinority Interest-8.7K-9.7K-52.2K-8.5K
 
 
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity7.1M14.6M5.2M1.7M
 
 
 
 
 
Total Shareholder Equity7.1M14.6M5.2M1.7M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding2.7M3.1M3.2M4.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.